Tuesday, December 11, 2012
4:00 P.M. to 9:00 P.M.
Newport Beach Marriott,
900 Newport Center Drive, Newport Beach, CA 92660
About our program
Companies in the dental, ophthalmic and medical aesthetic industry are pioneering the world of consumer-centric medicine, eschewing the traditional models of how medical device companies interact with customers. These companies are reaching past the physician and speaking directly to the customer, who is in most cases paying for services out of their own pocket.
As the provider community shifts away from fee-for-service models to cost-control measures such as bundled payment systems, the business model of the medical device industry must change too. Now, more than ever, device companies must look for new ways to reach an empowered patient. MassDevice is bringing together three CEOs of preeminent companies in each of these fields, including the inventor of the term medical aesthetics, Allergan CEO David Pyott for another evening of conversation among leaders at the MassDevice Big 100 West.
Join us as we peel back the curtain of the Medical Aesthetics Revolution and find out how the business of beauty can change the medical device industry.
What is the Big 100 Roundtable?
Check out some video from our most recent Big 100 Roundtable
Michael Mahoney, President, Boston Scientific
"The MassDevice Big 100 Roundtable West is a great opportunity for industry leaders to come together. As a featured guest at last year's event in Irvine, I was impressed with the quality of the conversation and the caliber of guests. Bringing together leaders to discuss the healthcare environment is essential to fostering community in the medical device industry. I go to many events but the MassDevice Big 100 Roundtable stands out as one of the best meetings our industry has to offer."
- Scott Huennekens, President & CEO Volcano Corporation, 2011 Big 100 West Panelist
"I was very happy I had the opportunity to come. You had a terrific turnout for the event ... "
- Dr. Jeffrey Shuren, Director, FDA's CDRH, 2011 Roundtable participant
Our featured guest for December 11th
David Pyott, Chairman, CEO, Allergan
Mr. Pyott joined Allergan in January 1998 as President and Chief Executive Officer (CEO) and now serves as Chairman of the Board (since 2001), President and CEO. Previously, he was head of the Nutrition Division and a member of the Executive Committee of Novartis AG from 1995 through 1997. Mr. Pyott has about 30 years of international experience in nutrition and health care and has worked in Austria, Germany, the Netherlands, Spain, Switzerland, Malaysia, Singapore, and the United Kingdom.
Our CEO Panel
Thomas Prescott, President/CEO, Align Technology
Mr. Prescott has served as President and CEO of Align Technology since March 2002. Previously, he was President and CEO of Cardiac Pathways, Inc., where he brought focus to the organization, launched new products and substantially grew the revenue run rate over a 24-month period. Prior to Cardiac Pathways, Mr. Prescott held various sales, general management and executive roles at Nellcor Puritan Bennett, Inc., and various management positions at GE Medical Systems. In addition, Mr. Prescott served in sales, marketing and management roles at Siemens. He earned his masters degree from Kellogg Graduate School of Management, Northwestern University in 1992 and his bachelors degree, with emphasis in Civil Engineering, from Arizona State University.
James Mazzo, SVP, Abbott Medical Optics
James Mazzo is Senior Vice President, Abbott Medical Optics, heading up the company's global vision care business. He was appointed to his current role in February 2009. Prior to joining Abbott upon the acquisition of Advanced Medical Optics, Mr. Mazzo served as its chairman and CEO. He also held various senior executive-level positions for Allergan prior to its spin-off of Advanced Medical Optics, including president of Allergan's Europe/Africa/Middle East region. Mr. Mazzo serves as chairman of the board of AdvaMed and chairman of the University of California at Irvine (UCI) Foundation board. He also serves on the UCI Dean’s Board of Directors’ Executive Committee and the UCI Dean’s Board of Business and Engineering. He is a trustee of Chapman University and the University of San Diego. Additionally, Mr. Mazzo is a member of the International Intraocular Implant Club and sits on the board of OCTANe.
Robert Grant, Chairman, Strathspey Crown
Mr. Grant brings his tremendous experience in innovation and dynamic growth for Fortune 500 companies to his role as Chairman of Strathspey Crown. For over 20 years, he has played a pivotal role in successful technology and business development in pharmaceutical, medical device, and healthcare markets. Most recently, he was CEO and President of Bausch+Lomb Surgical, leading the significant growth of their product portfolio. In 2006, Mr. Grant was President of Allergan Medical, leading the $3.2 billion Inamed acquisition and the commercial success of Botox Cosmetic, Juvederm, Natrelle breast implants, and Lap-Band brands. Beginning in 2003, Mr. Grant has served as Director, Chairman of the Board, CEO, President, COO, and CFO of Biolase Technology. From 1997–2003, he held various senior management positions at Lumenis.
David Gollaher, President and Chief Executive Officer CHI-California Healthcare Institute (Moderator)
David L. Gollaher, Ph.D., co-founded CHI in 1993. Previously, he was a senior executive at Scripps Clinic and Research Foundation. Earlier in his career, he served on the faculties of Harvard University, University of California, San Diego, the Graduate School of Public Health at SDSU, and the Overseas School of Rome. He is an award-winning historian of science and medicine, and has written three books and numerous articles in the fields of health policy, the economics of biomedical research and development, bioethics and the history of medicine.
Underwriting for the Big 100 provided by:
In Partnership with:
MassDevice.com is the online business journal for the medical device industry covering breaking news, information and analysis on the industry nationwide. Visit us online at www.massdevice.com.
Early Bird Rates end on Wednesday October, 31st. So please take advantage of the low, low rates by registering before hand.
Take a look at our recent interview with David Pyott for some background on our event and the guest of honor. Click here to read it.
Early bird rates have ended but there's still plenty of great deals to be had for this event if you register before 11/25.
Don't wait to join us.
Hotel room block for MassDevice event will be valid until 11/26. Special room rates are available by calling the hotel at (949) 640-4000.
Porzio Life Sciences’ regulatory compliance software solutions, products and services assist pharmaceutical, medical device and biotechnology companies in complying with marketing and sales regulations, including PDMA, anti-kickback statutes, False Claims Act, FDA, OIG, Physician Payments Sunshine Act and state aggregate spend compliance regulations.
Porzio AggregateSpendID is an automated web-based solution for spend and samples data capture, tracking and reporting. The system collects spend associated with sales representatives, senior executives, medical meetings, clinical trials, grants, eGrants, speaking fees, honoraria, etc.
Check Pozio Life Sciences out at: www.porziolifesciences.com
Switzerland Trade & Investment Promotion: Talent, innovation and the world’s most competitive environment. Europe’s highest density of Medtech companies producing medical devices, instruments and consumables for the world. From early stage to multinational, Switzerland has everything you need to succeed in Europe.
Visit us @ www.locationswitzerland.com
Contact: Daniel Bangser, Director North America: email@example.com
In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.